Latest filing published 22 Mar 2010 for Somaxon Pharmaceuticals, Inc., €7.0M.
Insider track record
No signal scores available.
Montreux Equity Partners II Sbic LP: trading record in brief
Montreux Equity Partners II Sbic LP appears in our data through filings on Somaxon Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 8 July 2009 to 18 March 2010, the count stands at 2 filings.
The open-market record consists of 1 sale worth €7.0M, with no purchase. Outside the open market, there are 1 share grant. Since January 2010: no purchases and 1 sale on the market.
On 22 March 2010 came the latest disclosure, an open-market sale for €7.0M in Somaxon Pharmaceuticals, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Montreux Equity Partners II Sbic LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500,000 shares@ US$6.3824Common StockSEC:0001104659-10-015701:0
- 851,062 shares@ US$1.05Common StockSEC:0001104659-09-042808:0
2 of 2 declarations